Cargando…

Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS)

BACKGROUND: In 2014, the American Academy of Pediatrics stopped recommending palivizumab to otherwise healthy 29–34 weeks’ gestational age (wGA) infants aged <12 months at respiratory syncytial virus (RSV) season start. Here, we compare the burden of RSV hospitalizations (RSVH) and all-cause bron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fergie, Jaime, Suh, Mina, Jiang, Xiaohui, Fryzek, Jon P, Gonzales, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974836/ https://www.ncbi.nlm.nih.gov/pubmed/32691037 http://dx.doi.org/10.1093/infdis/jiaa435

Ejemplares similares

2638. Respiratory Syncitial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among 29–34 Weeks Gestational Age (wGA) Preterm Infants Before and After the 2014 American Academy of Pediatrics (AAP) Immunoprophylaxis Policy Change Using the Children’s Hospital Association’s Pediatric Health Information System (PHIS)
por: Fergie, Jaime, et al.
Publicado: (2019)

1520. Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at the Start of RSV Season With Bronchopulmonary Dysplasia/Chronic Lung Disease of Prematurity (BPD/CLDP) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
por: Fergie, Jaime, et al.
Publicado: (2020)

1513. Medically Attended Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at RSV Season Start With Higher-Risk Congenital Heart Disease (CHD) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
por: Fergie, Jaime, et al.
Publicado: (2020)

Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018
por: Reichert, Heidi, et al.
Publicado: (2022)

Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review
por: Bylsma, Lauren C, et al.
Publicado: (2022)

Respiratory Syncytial Virus Binds and Undergoes Transcription in Neutrophils From the Blood and Airways of Infants With Severe Bronchiolitis
por: Halfhide, Clare P., et al.
Publicado: (2011)

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
por: Pastula, Susan T., et al.
Publicado: (2017)

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012
por: Doucette, Abigail, et al.
Publicado: (2016)

1636. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a disproportionate benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020
por: Nelson, Christopher B, et al.
Publicado: (2023)

743. Severity and Costs of Respiratory Syncytial Virus and Bronchiolitis Hospitalization in Commercially Insured Preterm and Term Infants Before and After the 2014 American Academy of Pediatrics Guidance Change on Immunoprophylaxis
por: Krilov, Leonard R, et al.
Publicado: (2018)

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample
por: Suh, Mina, et al.
Publicado: (2022)

Respiratory Syncytial Virus Genomic Load and Disease Severity Among Children Hospitalized With Bronchiolitis: Multicenter Cohort Studies in the United States and Finland
por: Hasegawa, Kohei, et al.
Publicado: (2015)

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019
por: Suh, Mina, et al.
Publicado: (2022)

Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
por: Movva, Naimisha, et al.
Publicado: (2022)

Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis
por: Buendia, Jefferson Antonio, et al.
Publicado: (2022)

National Bronchiolitis Hospitalization Rates Among Preterm and Full Term Infants: 2010–2015
por: Krilov, Leonard R, et al.
Publicado: (2017)

Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age
por: Franklin, Jeremy A., et al.
Publicado: (2016)

Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
por: Garcia-Mauriño, Cristina, et al.
Publicado: (2019)

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )
por: Suh, Mina, et al.
Publicado: (2022)

Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis
por: Fjaerli, Hans-Olav, et al.
Publicado: (2006)

Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection
por: Esposito, Susanna, et al.
Publicado: (2010)

The Source of Respiratory Syncytial Virus Infection In Infants: A Household Cohort Study In Rural Kenya
por: Munywoki, Patrick K., et al.
Publicado: (2014)

Respiratory Syncytial Virus Infection and Bronchiolitis
por: Piedimonte, Giovanni, et al.
Publicado: (2014)

Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study
por: GOUYON, J.-B., et al.
Publicado: (2013)

Respiratory Syncytial Virus in Outpatient Children with Bronchiolitis: Continuous Virus Circulation During the Nonepidemic Period
por: Rybak, Alexis, et al.
Publicado: (2023)

749. Healthcare Utilization After Hospitalization for Respiratory Syncytial Virus or Unspecified Bronchiolitis in the First Year of Life
por: Ledbetter, Joel, et al.
Publicado: (2018)

Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus
por: Scagnolari, Carolina, et al.
Publicado: (2012)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

Respiratory Syncytial Virus–Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis
por: McLaughlin, John M, et al.
Publicado: (2020)

735. Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29–34 Weeks Gestation: 2014–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

1413. Trends in Risk of Respiratory Syncytial Virus Hospitalizations in Preterm Infants Over a 10-Year Period
por: Kong, Amanda M, et al.
Publicado: (2020)

Group- and Genotype-Specific Neutralizing Antibody Responses Against Respiratory Syncytial Virus in Infants and Young Children With Severe Pneumonia
por: Sande, Charles J., et al.
Publicado: (2013)

Eosinophil Cationic Protein and Chemokines in Nasopharyngeal Secretions of Infants with Respiratory Syncytial Virus (RSV) Bronchiolitis and Non-RSV Bronchiolitis
por: Kim, Hyun Hee, et al.
Publicado: (2007)

Prospective Validation of a Prognostic Model for Respiratory Syncytial Virus Bronchiolitis in Late Preterm Infants: A Multicenter Birth Cohort Study
por: Blanken, Maarten O., et al.
Publicado: (2013)

Plasma Surfactant Protein-B Is Elevated in Infants with Respiratory Syncytial Virus-Induced Bronchiolitis
por: Wang, Shan-Ze, et al.
Publicado: (1999)

Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma
por: Raita, Yoshihiko, et al.
Publicado: (2021)

Clinical features of respiratory syncytial virus bronchiolitis in an infant: rapid and fatal brain involvement
por: Bottino, Paolo, et al.
Publicado: (2021)

The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya
por: Nyawanda, Bryan O, et al.
Publicado: (2020)

1406. Comparison of Clinical Presentations and Burden of Respiratory Syncytial Virus in Infants Across Three Distinct Healthcare Settings
por: Rankin, Danielle A, et al.
Publicado: (2020)

Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017
por: Fergie, Jaime, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1feqct54vccucu8ote1dkheftg